These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 7868892)

  • 21. Characterization of HLA-A 0201-restricted cytotoxic T cell epitopes in conserved regions of the HIV type 1 gp160 protein.
    Dupuis M; Kundu SK; Merigan TC
    J Immunol; 1995 Aug; 155(4):2232-9. PubMed ID: 7543542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-binding regions of HIV-1 proteins. II. A systematic study of viral proteins.
    Choppin J; Martinon F; Connan F; Pauchard M; Gomard E; Levy JP
    J Immunol; 1991 Jul; 147(2):575-83. PubMed ID: 1712812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes.
    Ishioka GY; Fikes J; Hermanson G; Livingston B; Crimi C; Qin M; del Guercio MF; Oseroff C; Dahlberg C; Alexander J; Chesnut RW; Sette A
    J Immunol; 1999 Apr; 162(7):3915-25. PubMed ID: 10201910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in HIV-1 Capsid Stability Induced by Common Cytotoxic-T-Lymphocyte-Driven Viral Sequence Mutations.
    Schommers P; Martrus G; Matschl U; Sirignano M; Lütgehetmann M; Richert L; Hope TJ; Fätkenheuer G; Altfeld M
    J Virol; 2016 Aug; 90(16):7579-7586. PubMed ID: 27279617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequence conservation of subdominant HLA-A2-binding CTL epitopes in HIV-1 clinical isolates and CD8+ T-lymphocyte cross-recognition may explain the immune reaction in infected individuals.
    Thorn M; Tang S; Therrien D; Kløverpris H; Vinner L; Kronborg G; Gerstoft J; Corbet S; Fomsgaard A
    APMIS; 2007 Jun; 115(6):757-68. PubMed ID: 17550385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus.
    Klenerman P; Meier UC; Phillips RE; McMichael AJ
    Eur J Immunol; 1995 Jul; 25(7):1927-31. PubMed ID: 7542596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition.
    Phillips RE; Rowland-Jones S; Nixon DF; Gotch FM; Edwards JP; Ogunlesi AO; Elvin JG; Rothbard JA; Bangham CR; Rizza CR
    Nature; 1991 Dec; 354(6353):453-9. PubMed ID: 1721107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells.
    Zweerink HJ; Gammon MC; Utz U; Sauma SY; Harrer T; Hawkins JC; Johnson RP; Sirotina A; Hermes JD; Walker BD
    J Immunol; 1993 Mar; 150(5):1763-71. PubMed ID: 7679694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and characterization of multiple HLA-A24-restricted HIV-1 CTL epitopes: strong epitopes are derived from V regions of HIV-1.
    Ikeda-Moore Y; Tomiyama H; Miwa K; Oka S; Iwamoto A; Kaneko Y; Takiguchi M
    J Immunol; 1997 Dec; 159(12):6242-52. PubMed ID: 9550428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA-B27 subtype polymorphism and CTL epitope choice: studies with EBV peptides link immunogenicity with stability of the B27:peptide complex.
    Brooks JM; Colbert RA; Mear JP; Leese AM; Rickinson AB
    J Immunol; 1998 Nov; 161(10):5252-9. PubMed ID: 9820497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection.
    Allen TM; Altfeld M; Yu XG; O'Sullivan KM; Lichterfeld M; Le Gall S; John M; Mothe BR; Lee PK; Kalife ET; Cohen DE; Freedberg KA; Strick DA; Johnston MN; Sette A; Rosenberg ES; Mallal SA; Goulder PJ; Brander C; Walker BD
    J Virol; 2004 Jul; 78(13):7069-78. PubMed ID: 15194783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peptide presentation to an alloreactive CTL clone is modulated through multiple mechanisms involving polymorphic and conserved residues in HLA-B27.
    García-Peydró M; Paradela A; Lamas JR; López De Castro JA
    J Immunol; 1999 Dec; 163(11):6060-4. PubMed ID: 10570294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS.
    Tomiyama H; Miwa K; Shiga H; Moore YI; Oka S; Iwamoto A; Kaneko Y; Takiguchi M
    J Immunol; 1997 May; 158(10):5026-34. PubMed ID: 9144523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conservation and alteration of HLA-B27-specific T cell epitopes on mouse cells. Implications for peptide-mediated alloreactivity.
    Rojo S; López D; Calvo V; López de Castro JA
    J Immunol; 1991 Jan; 146(2):634-42. PubMed ID: 1702810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation on immunogenicity by HLA-B27 subtype polymorphism.
    Jaraquemada D; Galocha B; Aparicio P; Rojo S; Calvo V; López de Castro JA
    Eur J Immunol; 1988 Dec; 18(12):1945-50. PubMed ID: 2464494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural homologies between two HLA B27-restricted peptides suggest residues important for interaction with HLA B27.
    Huet S; Nixon DF; Rothbard JB; Townsend A; Ellis SA; McMichael AJ
    Int Immunol; 1990; 2(4):311-6. PubMed ID: 2126195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV evolution: CTL escape mutation and reversion after transmission.
    Leslie AJ; Pfafferott KJ; Chetty P; Draenert R; Addo MM; Feeney M; Tang Y; Holmes EC; Allen T; Prado JG; Altfeld M; Brander C; Dixon C; Ramduth D; Jeena P; Thomas SA; St John A; Roach TA; Kupfer B; Luzzi G; Edwards A; Taylor G; Lyall H; Tudor-Williams G; Novelli V; Martinez-Picado J; Kiepiela P; Walker BD; Goulder PJ
    Nat Med; 2004 Mar; 10(3):282-9. PubMed ID: 14770175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza virus CTL epitopes, remarkably conserved and remarkably variable.
    Rimmelzwaan GF; Kreijtz JH; Bodewes R; Fouchier RA; Osterhaus AD
    Vaccine; 2009 Oct; 27(45):6363-5. PubMed ID: 19840674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection.
    Brumme ZL; Tao I; Szeto S; Brumme CJ; Carlson JM; Chan D; Kadie C; Frahm N; Brander C; Walker B; Heckerman D; Harrigan PR
    AIDS; 2008 Jul; 22(11):1277-86. PubMed ID: 18580606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TCR usage by homocysteine-specific human CTL.
    Chilvers MM; Wordsworth P; Stubbs A; Gao XM
    J Immunol; 1998 Apr; 160(8):3737-42. PubMed ID: 9558075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.